114 related articles for article (PubMed ID: 21512341)
1. Disruptive effects of the prototypical cannabinoid Δ⁹-tetrahydrocannabinol and the fatty acid amide inhibitor URB-597 on go/no-go auditory discrimination performance and olfactory reversal learning in rats.
Sokolic L; Long LE; Hunt GE; Arnold JC; McGregor IS
Behav Pharmacol; 2011 Jun; 22(3):191-202. PubMed ID: 21512341
[TBL] [Abstract][Full Text] [Related]
2. Comparisons of Δ9-Tetrahydrocannabinol and Anandamide on a Battery of Cognition-Related Behavior in Nonhuman Primates.
Kangas BD; Leonard MZ; Shukla VG; Alapafuja SO; Nikas SP; Makriyannis A; Bergman J
J Pharmacol Exp Ther; 2016 Apr; 357(1):125-33. PubMed ID: 26826191
[TBL] [Abstract][Full Text] [Related]
3. The fatty acid amide hydrolase inhibitor URB 597: interactions with anandamide in rhesus monkeys.
Stewart JL; McMahon LR
Br J Pharmacol; 2011 Sep; 164(2b):655-66. PubMed ID: 21449917
[TBL] [Abstract][Full Text] [Related]
4. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport.
Solinas M; Tanda G; Justinova Z; Wertheim CE; Yasar S; Piomelli D; Vadivel SK; Makriyannis A; Goldberg SR
J Pharmacol Exp Ther; 2007 Apr; 321(1):370-80. PubMed ID: 17210800
[TBL] [Abstract][Full Text] [Related]
5. Alterations in behavioral flexibility by cannabinoid CB1 receptor agonists and antagonists.
Hill MN; Froese LM; Morrish AC; Sun JC; Floresco SB
Psychopharmacology (Berl); 2006 Aug; 187(2):245-59. PubMed ID: 16752140
[TBL] [Abstract][Full Text] [Related]
6. FAAH inhibitor, URB-597, promotes extinction and CB(1) antagonist, SR141716, inhibits extinction of conditioned aversion produced by naloxone-precipitated morphine withdrawal, but not extinction of conditioned preference produced by morphine in rats.
Manwell LA; Satvat E; Lang ST; Allen CP; Leri F; Parker LA
Pharmacol Biochem Behav; 2009 Nov; 94(1):154-62. PubMed ID: 19698735
[TBL] [Abstract][Full Text] [Related]
7. Benzodiazepines impair the acquisition and reversal of olfactory go/no-go discriminations in rats.
Sokolic L; McGregor IS
Behav Neurosci; 2007 Jun; 121(3):527-34. PubMed ID: 17592943
[TBL] [Abstract][Full Text] [Related]
8. Discriminative stimulus effects of the cannabinoid antagonist, SR 141716A, in delta -sup-9-tetrahydrocannabinol-treated rhesus monkeys.
McMahon LR; France CP
Exp Clin Psychopharmacol; 2003 Nov; 11(4):286-93. PubMed ID: 14599262
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.
Walentiny DM; Vann RE; Wiley JL
Neuropharmacology; 2015 Jun; 93():237-42. PubMed ID: 25698527
[TBL] [Abstract][Full Text] [Related]
10. Delta 9-tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism.
Lichtman AH; Martin BR
Psychopharmacology (Berl); 1996 Jul; 126(2):125-31. PubMed ID: 8856831
[TBL] [Abstract][Full Text] [Related]
11. Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide.
Solinas M; Scherma M; Tanda G; Wertheim CE; Fratta W; Goldberg SR
J Pharmacol Exp Ther; 2007 Jun; 321(3):1127-34. PubMed ID: 17351107
[TBL] [Abstract][Full Text] [Related]
12. Tolerance to the disruptive effects of Delta(9)-THC on learning in rats.
Delatte MS; Winsauer PJ; Moerschbaecher JM
Pharmacol Biochem Behav; 2002 Dec; 74(1):129-40. PubMed ID: 12376160
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of learning and memory impairment induced by delta9-tetrahydrocannabinol in rats.
Mishima K; Egashira N; Hirosawa N; Fujii M; Matsumoto Y; Iwasaki K; Fujiwara M
Jpn J Pharmacol; 2001 Dec; 87(4):297-308. PubMed ID: 11829149
[TBL] [Abstract][Full Text] [Related]
14. Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice.
Haller VL; Cichewicz DL; Welch SP
Eur J Pharmacol; 2006 Sep; 546(1-3):60-8. PubMed ID: 16919265
[TBL] [Abstract][Full Text] [Related]
15. Cannabinergic aminoalkylindoles, including AM678=JWH018 found in 'Spice', examined using drug (Δ(9)-tetrahydrocannabinol) discrimination for rats.
Järbe TU; Deng H; Vadivel SK; Makriyannis A
Behav Pharmacol; 2011 Sep; 22(5-6):498-507. PubMed ID: 21836461
[TBL] [Abstract][Full Text] [Related]
16. Olfactory repeated discrimination reversal in rats: effects of chlordiazepoxide, dizocilpine, and morphine.
Galizio M; Miller L; Ferguson A; McKinney P; Pitts RC
Behav Neurosci; 2006 Oct; 120(5):1175-9. PubMed ID: 17014269
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant-like effects of Δ⁹-tetrahydrocannabinol and rimonabant in the olfactory bulbectomised rat model of depression.
Elbatsh MM; Moklas MA; Marsden CA; Kendall DA
Pharmacol Biochem Behav; 2012 Aug; 102(2):357-65. PubMed ID: 22634064
[TBL] [Abstract][Full Text] [Related]
18. Effects of MK-801 on vicarious trial-and-error and reversal of olfactory discrimination learning in weanling rats.
Griesbach GS; Hu D; Amsel A
Behav Brain Res; 1998 Dec; 97(1-2):29-38. PubMed ID: 9867228
[TBL] [Abstract][Full Text] [Related]
19. Role of cannabinoidergic mechanisms in ethanol self-administration and ethanol seeking in rat adult offspring following perinatal exposure to Delta9-tetrahydrocannabinol.
Economidou D; Mattioli L; Ubaldi M; Lourdusamy A; Soverchia L; Hardiman G; Campolongo P; Cuomo V; Ciccocioppo R
Toxicol Appl Pharmacol; 2007 Aug; 223(1):73-85. PubMed ID: 17618662
[TBL] [Abstract][Full Text] [Related]
20. Acute delta9-tetrahydrocannabinol-induced deficits in reversal learning: neural correlates of affective inflexibility.
Egerton A; Brett RR; Pratt JA
Neuropsychopharmacology; 2005 Oct; 30(10):1895-905. PubMed ID: 15812570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
